Cover Image

Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1

UDP-glucuronosyltransferase 1A1 (UGT1A1) plays a key role in detoxification of many potentially harmful compounds and drugs. UGT1A1 inhibition may bring risks of drug-drug interactions (DDIs), hyperbilirubinemia and drug-induced liver injury. This study aimed to investigate and compare the inhibitor...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xuewei Cheng (Author), Xia Lv (Author), Hengyan Qu (Author), Dandan Li (Author), Mengmeng Hu (Author), Wenzhi Guo (Author), Guangbo Ge (Author), Ruihua Dong (Author)
Format:	Book
Published:	Elsevier, 2017-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quantitative analysis of the UDP‐glucuronosyltransferase transcriptome in human tissues
by: Lucas Zhou, et al.
Published: (2023)

Structure and protein-protein interactions of human UDP-glucuronosyltransferases
by: Ryoichi Fujiwara, et al.
Published: (2016)

Dysregulated hepatic UDP-glucuronosyltransferases and flavonoids glucuronidation in experimental colitis
by: Wanying Zeng, et al.
Published: (2022)

Effects of variation status and enzyme activity for UDP-glucuronosyltransferase 1A1 gene on neonatal hyperbilirubinemia
by: May-Jen Huang, et al.
Published: (2020)

Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1
by: Hui-Lin Pang, et al.
Published: (2022)

Age-dependent Hepatic UDP-glucuronosyltransferase Gene Expression and Activity in Children
by: Elizabeth Neumann, et al.
Published: (2016)

Inhibitory effects of tanshinones towards the catalytic activity of UDP-glucuronosyltransferases (UGTs)
by: Xu-Xin Zhang, et al.
Published: (2017)

Molecular biology of glucose-6-phosphate dehydrogenase and UDP-glucuronosyltransferase 1A1 in the development of neonatal unconjugated hyperbilirubinemia
by: Yi-Li Hung, et al.
Published: (2024)

Intestinal UDP-glucuronosyltransferase as a potential target for the treatment and prevention of lymphatic filariasis.
by: Alexander F Flynn, et al.
Published: (2019)

Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells
by: Monivan Chhour, et al.
Published: (2021)

Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen
by: Huma Mehboob, et al.
Published: (2017)

Tetrahydrofurofuranoid Lignans, Eudesmin, Fargesin, Epimagnolin A, Magnolin, and Yangambin Inhibit UDP-Glucuronosyltransferase 1A1 and 1A3 Activities in Human Liver Microsomes
by: Ria Park, et al.
Published: (2021)

17β-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expression via estrogen receptor α
by: Sung-joon Cho, et al.
Published: (2016)

Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances
by: Yun Sheng, et al.
Published: (2021)

Human UDP-Glucuronosyltransferase 2B4 and 2B7 Are Responsible for Naftopidil Glucuronidation in Vitro
by: Xia-Wen Liu, et al.
Published: (2018)

Contributions of UDP-Glucuronosyltransferases to Human Hepatic and Intestinal Metabolism of Ticagrelor and Inhibition of UGTs and Cytochrome P450 Enzymes by Ticagrelor and its Glucuronidated Metabolite
by: Shuaibing Liu, et al.
Published: (2021)

UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data
by: Apolonia Novillo, et al.
Published: (2018)

Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions
by: Zifei Qin, et al.
Published: (2020)

Frequency of dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase 1A1 variants in cancer patients requiring chemotherapy: A single-center study in southern India
by: Kevin Nischay Gangavarapu, et al.
Published: (2023)

Exploring the Metabolism of Loxoprofen in Liver Microsomes: The Role of Cytochrome P450 and UDP-Glucuronosyltransferase in Its Biotransformation
by: Riya Shrestha, et al.
Published: (2018)

Identification of Catalposide Metabolites in Human Liver and Intestinal Preparations and Characterization of the Relevant Sulfotransferase, UDP-glucuronosyltransferase, and Carboxylesterase Enzymes
by: Deok-Kyu Hwang, et al.
Published: (2019)

Pharmacokinetic drug-drug interactions of JBPOS0101 mediated by cytochrome P450 3A4 and UDP‐glucuronosyltransferases
by: Sejung Hwang, et al.
Published: (2024)

INTRODUCTION OF AN N-GLYCOSYLATION SITE INTO UDP-GLUCURONOSYLTRANSFERASE 2B3 ALTERS ITS SENSITIVITY TO CYTOCHROME P450 3A1-DEPENDENT MODULATION
by: Tatsuro Nakamura, et al.
Published: (2016)

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
by: Long-fei Mao, et al.
Published: (2020)

The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco‐2 monolayer model by interacting with UDP‐glucuronosyltransferases and efflux transport proteins
by: Siyuan Cao, et al.
Published: (2022)

Metabolism of 2,3-Dehydrosilybin A and 2,3-Dehydrosilybin B: A Study with Human Hepatocytes and Recombinant UDP-Glucuronosyltransferases and Sulfotransferases
by: Jiří Vrba, et al.
Published: (2021)

Prevalence of UDP-glucuronosyltransferase polymorphisms (UGT1A6∗2, 1A7∗12, 1A8∗3, 1A9∗3, 2B7∗2, and 2B15∗2) in a
by: Khalid M. Alkharfy, et al.
Published: (2017)

Rosacea-Like Dermatitis Caused by Icotinib Hydrochloride: A Case Report
by: Pei-Pei Liu, et al.
Published: (2019)

Design, synthesis and biological evaluation of erlotinib-based IDO1 inhibitors
by: Xi-xi Hou, et al.
Published: (2022)

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
by: Peng Deng, et al.
Published: (2022)

Integrate thermostabilized fusion protein apocytochrome b562RIL and N-glycosylation mutations: A novel approach to heterologous expression of human UDP-glucuronosyltransferase (UGT) 2B7
by: Jia Xue, et al.
Published: (2022)

Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
by: Xiaojie Chen, et al.
Published: (2022)

Recent progress and challenges in screening and characterization of UGT1A1 inhibitors
by: Xia Lv, et al.
Published: (2019)

LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
by: Jie Wu, et al.
Published: (2021)

Modified Synthesis of Erlotinib Hydrochloride
by: Leila Barghi, et al.
Published: (2012)

Correction to: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
by: Jie Wu, et al.
Published: (2021)

Correction: LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/ miR-324-3p-SIRT5 axis in lung adenocarcinoma
by: Jie Wu, et al.
Published: (2023)

Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib
by: Yin N, et al.
Published: (2020)

Acute generalized exanthematous pustulosis induced by icotinib: a case report and literature review
by: Wei Yang, et al.
Published: (2024)

Depletion of UDP-Glucose and UDP-Galactose Using a Degron System Leads to Growth Cessation of Leishmania major.
by: Sebastian Damerow, et al.
Published: (2015)